Open-Label Safety Study of ADS-5102 in PD Patients With LID

Clinical trial NCT02202551 · COMPLETED

Trial details

NCT number: NCT02202551
Sponsor: Adamas Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Dyskinesia Levodopa Induced Dyskinesia (LID)Parkinson's Disease (PD)

Start date: 2014-07-01
Primary completion: 2018-02-01
Enrollment: 223

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.